Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (222K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bernues, J
Right arrow Articles by Azorin, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernues, J
Right arrow Articles by Azorin, F
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 2950-2959

Footnote

TBP binds the transcriptionally inactive TA 5 sequence but the resulting complex is not efficiently recognised by TFIIB and TFIIA

TBP binds the transcriptionally inactive TA 5 sequence but the resulting complex is not efficiently recognised by TFIIB and TFIIA Jordi Bernués , Pilar Carrera + and Fernando Azorín*

Dept. Biologia Molecular i Cellular, Centre d'Investigació i Desenvolupament CSIC, Jordi Girona 18-26, 08034 Barcelona , Spain

Received April 16, 1996; Revised and Accepted June 17, 1996

ABSTRACT

The binding of TBP (TFIID) to the TATA box has been considered to direct promoter recognition and pre-initiation complex formation because it is the first event leading to basal transcription by RNA polymerase II. Here, we analyse the binding of yeast TBP to a consensus TATAAA box and two point mutations, TAAAAA (inactive) and TATATA (active). Despite the fact that the TAAAAA sequence does not support transcription in vitro , yeast TBP binds the three sequences showing, in this sense, only a limited sequence specificity. However, the TBP-TAAAAA complex cannot be recognised by other basal transcription factors, in particular by TFIIB. DNase I footprinting patterns of the TBP-TAAAAA complex are different from those observed in functional TBP-TATA box complexes, indicating that, most likely, it is a different spatial arrangement of the TBP-DNA complex that prevents formation of the TFIIB-TBP-TAAAAA complex, also seriously impairing entry of TFIIA to the complex. DNA deformability of the A/T-rich sequences appears to be an important determinant in the formation of a productive TBP-TATA complex. These results indicate that the transcriptional competence of A/T-rich sequences is determined not only by TBP binding, but also by the ability of other basal transcription factors to recognise the preformed TBP-DNA complexes.

INTRODUCTION

Assembly of the RNA polymerase II transcription machinery onto a TATA box-containing promoter is known to follow a well-defined pathway that ultimately leads to the recruitment of RNA polymerase II and transcription initiation ( 1 ). TFIID, through its TATA box binding protein (TBP) subunit, is the first transcription factor to interact with the TATA box. Other basal transcription factors, TFIIB and TFIIA, sequentially interact with this initial complex in the formation of a complete pre-initiation complex (reviewed in 2 , 3 ). As TBP is the only basal transcription factor with DNA binding specificity, it has been widely accepted that TBP binding leads to promoter commitment. TBP binds the TATA box consensus core sequence (TATAAA) with high affinity ( K d = 2-4 * 10 -9 M). However, the molecular basis of this specific recognition is still poorly understood. TBP interacts with TATA boxes in the minor groove ( 4 , 5 ), where it is almost impossible to discriminate between many different A/T-rich sequences. Actually, depending on the promoter and the organism, many other sequences have been found to bind TBP and be functionally active in transcription. Recently, the crystal structures of Arabidopsis ( 6 ) and yeast ( 7 ) TBPs and of their co-crystals with two different TATA boxes have been obtained ( 8 , 9 ). The crystals have revealed a very similar structure of a saddle in both cases. From the co-crystal structures, TBPs were shown to interact on the concave surface of the saddle with 8 bp of DNA encompassing the core TATA box; the interaction takes place in the minor groove and, in good agreement with previously reported results ( 10 ), produces a dramatic bending of the DNA without major distortions in the TBP structure itself. The co-crystal structures show extensive interactions with the nucleic acid backbone, which include salt bridges, water-mediated hydrogen bonds and van der Waals contacts with the sugar groups. Interactions with the bases also include van der Waals contacts and the formation of a few specific hydrogen bond interactions, occurring at the very center of the TATA box sequence, involving the symmetrical and stereochemically equivalent groups O2 of thymine and N3 of adenine. Altogether, the interactions observed in the co-crystals explain in part the lack of discrimination between A.T and T.A base pairs.

However, it has been clearly shown both in vitro and in vivo that some A/T point mutations in the TATA core sequence have strong effects on transcriptional rates ( 11 , 12 ). In particular, replacement of T(-29) in the consensus TATA box sequence by an adenine is known to abolish transcription almost completely.

In order to gain some insight on how the transcription machinery discriminates between wild-type (active) and mutated (inactive) TATA boxes when only A/T changes are introduced, we have studied the interaction of TBP with a set of artificial basal promoters in which we introduced either a consensus TATAAA box or mutated TAAAAA and TATATA sequences. Our results show that TBP binds to all three sequences giving rise to complexes of similar stabilities, despite the TAAAAA sequence not being able to direct transcription in vitro . A different structural organisation of the TBP-TAAAAA complex impairs formation of the TFIIB-TBP-, TFIIA-TBP- and TFIIA-TFIIB-TBP-TAAAAA complexes and appears to be responsible for the observed lack of activity.

MATERIALS AND METHODS

Construction of templates and expression and purification of transcription factors

The WT, TA 5 and (TA) 3 oligonucleotides were synthesized by the phosphoroamidite method on an Applied Biosystems synthesizer. The WT double-stranded oligonucleotide was inserted into a G-less[180] plasmid between the Eco RI and Sst I (made blunt by T4 DNA pol digestion) sites. Subsequently, TA 5 and (TA) 3 were inserted by replacement in the WT construct using the Eco RI and Sst I sites.

Recombinant his-tagged yeast TBP from the pET14b expression vector (Novagen) was overexpressed in Escherichia coli strain BL21(DE3) pLys E. Two hours after induction by addition of IPTG at up to 1 mM, cells were collected and lysed by sonication in lysis buffer (0.5 M NaCl, 20 mM HEPES, pH 7.9, 1 mM EDTA, 20 mM 2-mercaptoethanol, 0.1% NP-40, 1 mM PMSF, 20% glycerol; 30 ml/l culture). The homogenate was clarified by centrifugation (100 000 g , 1 h, 4oC), the supernatant loaded onto a 10 ml DEAE-Sephadex A25 column and the flow-through applied to a 1 ml Ni 2+ -NTA column pre-equilibrated in lysis buffer. After extensive washing with lysis buffer and buffer D (0.1 M KCl, 20 mM HEPES, pH 7.9, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol, 0.1 mM PMSF), the column was eluted with buffer D containing 100 mM imidazole. All steps were carried out at 4oC. The fractions containing highly purified his-tagged yTBP were determined by SDS-PAGE electrophoresis and stored at -80oC. The his-tag peptide was removed by thrombin digestion, as suggested by the manufacturer (Novagen). The purity of the yTBP used was >95%.

Recombinant non-tagged human TFIIB protein was expressed in E.coli BL21(DE3) and purified as described ( 13 ). The purity as assessed by SDS-PAGE was ~95%.

Human TFIIA was purified from nuclear extracts of HeLa cells exactly as described ( 14 ).

In vitro transcription reactions

Nuclear extracts were prepared from HeLa cells and fractionated as described ( 15 ). In our assays, a phosphocellulose 0.5 M fraction was used as a source of general transcription factors and RNA polymerase II because this fraction does not support polymerase II transcription on its own (see lane 1 in Fig. 4 C). In vitro transcription analysis was performed using 4-8 [mu]l (~10-20 [mu]g protein) of this fraction and 1 [mu]l (~100 ng protein) of recombinant yTBP. The amounts of the three supercoiled templates used were carefully normalised by restriction enzyme digestion and analysis by agarose gel electrophoresis. Transcription reactions were carried out as described ( 15 ). Unrelated T7-transcribed RNAs were added to the samples prior to phenol extraction and precipitation as recovery controls. Gels were dried and exposed to X-ray-sensitive film at -80oC with intensifying screens.

Electrophoretic mobility shift analysis

Reaction mixtures contained 25 mM HEPES, pH 7.9, 45 mM KCl, 2 mM spermidine, 0.1 mM EDTA, 0.025% NP-40, 5 mM MgCl 2 , 15% glycerol, 0.5 mM DTT and 20-120 ng poly(dG[middot]dC) and 50 ng acetylated BSA. Increasing amounts of the final yTBP preparation were incubated, for 30-40 min at 30oC, with 0.5-1 ng 32 P-labeled double-stranded oligonucleotides in a final volume of 20 [mu]l. For simple yTBP shift analysis samples were directly loaded onto 5% polyacrylamide gels containing 25 mM Tris, 190 mM glycine, 5 mM MgCl 2 , 1 mM EDTA, 10% glycerol, 0.5 mM DTT; the running buffer was the same except that DTT was replaced by 5 mM 2-mercaptoethanol and glycerol was omitted ( 16 ). Quantification was performed by scanning and integration of the autoradiographs using a Molecular Dynamics laser densitometer. Oligonucleotide competition experiments were performed under exactly the same conditions by prior mixing all of the reagents and increasing amounts of cold oligonucleotides before yTBP addition. Formation of the TFIIB-TBP-DNA, TFIIA-TBP-DNA and TFIIA-TFIIB-TBP-DNA complexes was assayed under the same conditions of incubation and analysed on 4% polyacrylamide gels containing 25 mM Tris, 190 mM glycine, 0.5 mM DTT; the running buffer was the same except that DTT was omitted ( 17 ). Gels were dried and exposed to X-ray-sensitive film at -80oC with intensifying screens.


Figure 1 . Functional assay as TATA boxes of the three A/T sequences studied here. ( A ) Sequences of the three oligonucleotides used for the assays. The differences in the TATA box sequences are outlined (see the text for details). ( B ) The three oligonucleotides described in (A) were fused to a G-less[180] cassette and their ability to drive basal transcription dependent on yeast TBP assayed in vitro as a function of increasing amounts of each supercoiled template: 100 (lanes 1, 4 and 7); 200 (lanes 2, 5 and 8); 500 ng (lanes 3, 6 and 9). All experiments were performed as described in Materials and Methods in the presence of 100 ng yTBP. The positions of a recovery control (*) and full-length transcripts (+1) are indicated.


DNase I footprinting analysis

DNase I footprinting analysis was performed using exactly the same conditions as described for the simple yTBP EMSA. After incubation samples were digested with 1.5 [mu]l DNase I (5 * 10 -3 U) for exactly 60 s at 30oC. Reactions were stopped by addition of 200 [mu]l 0.1 M NaCl, 50 mM Tris-HCl, pH 8, 0.5% SDS, extracted with phenol/chloroform and ethanol precipitated. G+A ladders were obtained by chemical sequencing. Digestion products were analysed on denaturing 20% polyacrylamide gels and directly exposed to X-ray-sensitive film at -80oC with intensifying screens. Quantitative analysis of the results was performed by densitometric scanning of the autoradiographs using a Molecular Dynamics laser densitometer. The intensities of the bands in the protected region were integrated and referred to the intensity observed for the same region in naked DNA of the corresponding sequence. The same region was considered for all three sequences, despite protection on TA 5 being weaker on the 5'-half.

Circular permutation analysis

The WT, TA 5 and (TA) 3 sequences were subcloned as blunt-end inserts at the unique Sal I site (made blunt) of pBend 2 ( 18 ) and checked by sequencing. Each construct was digested separately with Bgl II, Pvu II and Bam HI to produce a 175 bp band having the insert at 134, 87 and 35 bp from one of the ends respectively and analysed on 30 cm long 7% polyacrylamide-TBE gels run at 150 V for 18 h at 4oC. Bands were visualized by ethidium bromide staining and photographed under UV light.

RESULTS

TBP binds the transcriptionally inactive TA 5 sequence

In order to study how TBP recognises TATA boxes, we have designed a set of artificial basal promoters in which we have introduced either a consensus TATAAA box, a TAAAAA sequence [in which T(-29) of the consensus TATA box was replaced by an A], or a TATATA sequence [in which A(-27) was replaced by a T] (abbreviated as WT, TA 5 and (TA) 3 respectively in Fig. 1 A). These sequences were fused to a G-less cassette and tested in an in vitro transcription assay dependent on added TBP (Fig. 1 B). As expected ( 12 ), TA 5 does not support basal transcription, whereas WT and (TA) 3 direct almost equivalent levels of transcription at the three template concentrations tested when yeast TBP is added. TA 5 cannot direct transcription even in the presence of TFIID or in crude HeLa nuclear extracts (results not shown). Thus, the T(-29) -> A change in TA 5 renders the promoter totally inactive in transcription, in agreement with results obtained in vivo in yeast cells ( 11 ).

The interaction of yTBP with the three different A/T sequences indicated above was studied by EMSA. As shown in Figure 2 A, the formation of specific TBP-DNA complexes was detected with all three sequences. Moreover, similar amounts of complex were detected with the WT and TA 5 sequences (Fig. 2 A and C), indicating that the complexes formed with these sequences have a similar relative stability. On the other hand, the amount of complex formed with the (TA) 3 sequence is significantly higher (Fig. 2 A and C). Identical results were obtained using human TBP (not shown). These results were further confirmed by oligonucleotide competition assays. In these experiments binding of yTBP to the WT sequence was competed equally well by WT or TA 5 and much better by (TA) 3 (Fig. 2 B). Complementary experiments using TA 5 or (TA) 3 against all three cold oligonucleotides gave the same results, whereas large amounts of non-specific competitors [poly(dG[middot]dC)] had no effect (not shown).


Figure 2 . Transcriptional efficiency of the WT, TA 5 and (TA) 3 sequences does not correlate with their ability to form the yTBP-DNA complex. ( A ) Binding of yTBP to the WT, TA 5 and (TA) 3 sequences was studied by EMSA as a function of increasing amounts of yTBP: 0 (lanes 1, 6 and 11); 3 (lanes 2, 7 and 12); 9 (lanes 3, 8 and 13); 12 (lanes 4, 9 and 14); 36 ng (lanes 5, 10 and 15). The position corresponding to the yTBP-DNA complex is indicated. F, free oligonucleotides. ( B ) Competition of binding of yTBP to the WT sequence by the WT, TA 5 and (TA) 3 sequences. yTBP (20 ng) was incubated with a constant amount of 32 P-labeled WT oligonucleotide in the presence of increasing amounts of the corresponding cold specific competitor DNA: 0 (lane 2); 10 (lanes 3, 6 and 9); 100 (lanes 4, 7 and 10); 200 ng (lanes 5, 8 and 11). As a control, lane 1 does not contain yTBP. The position corresponding to the yTBP-DNA complex is indicated. F, free oligonucleotides. ( C ) Quantitative analysis of the results shown in (A). The percentage of binding of yTBP to the WT, TA 5 and (TA) 3 sequences was determined as a function of increasing amounts of yTBP and normalized with respect to the binding obtained with the WT sequence: ([squ]-[squ]) WT; ([circle]---[circle]) TA 5 ; ([diamonds][middot][middot][middot][middot][diamonds]) (TA) 3 .


Similar results were obtained by quantitative DNase I footprinting. As shown in Figure 3 , addition of increasing amounts of yTBP results in very clear footprints which are detected on both strands for all three sequences studied. The footprints span very similar regions centred around the A/T sequences in all three cases, indicating that also in the case of the inactive TA 5 sequence, the complex formed with TBP results from specific interaction with the TAAAAA sequence. As judged from the amounts of yTBP required to observe similar degrees of DNase I protection, the affinity of yTBP for the TA 5 sequence is slightly lower, by a factor of around five, than for either WT or (TA) 3 (Fig. 3 C). Similar differences in affinity have been reported between different functional TATA sequences ( 19 ).


Figure 3 . Quantitative DNase I footprinting of the binding of yTBP to the WT, TA 5 and (TA) 3 sequences. ( A ) The DNase I footprints observed on the top strand of the three sequences are presented as a function of increasing amounts of yTBP: 0 (lanes 2, 6 and 10); 6 (lanes 3, 7 and 11); 12 (lanes 4, 8 and 12); 30 ng (lanes 5, 9 and 13). Lane 1 is a G+A ladder of the WT sequence. Brackets indicate the positions protected by yTBP. ( B ) As in (A) but for the bottom strand: 0 (lanes 2, 7 and 12); 10 (lanes 3, 8 and 13); 20 (lanes 4, 9 and 14); 50 (lanes 5, 10 and 15); 100 ng (lanes 6, 11 and 16). Lane 1 is a G+A ladder of the WT sequence. Brackets indicate the positions protected by yTBP. ( C ) Quantitative analysis of the results shown in (A). The percentage of digestion determined as described in Materials and Methods is presented as a function of increasing yTBP for: ([squ]-[squ]) WT; ([circle]---[circle]) (TA) 3 ; ([diamonds][middot][middot][middot][middot][diamonds]) TA 5 . ( D ) Summary of the results of DNase I footprinting analysis. Boxes indicate the residues protected from DNase I digestion. Full grey boxes indicate uniform protection to DNase I digestion, gradient grey boxes represent gradual protection. In the case of the TA 5 sequence, asterisks denote residues A(-29) and A(-30), which are particularly sensitive to DNase I cleavage (see details in text).


Figure 4 . TFIIA and TFIIB cannot efficiently assemble onto the yTBP-TA 5 complex. ( A ) Formation of the TFIIB-yTBP-DNA complex on the WT, TA 5 and (TA) 3 sequences was analysed by EMSA as a function of increasing amounts of recombinant hTFIIB: 0 (lanes 2, 8 and 14); 8 (lanes 3, 9 and 15); 16 (lanes 4, 10 and 16); 24 ng (lanes 5, 11 and 17). In all cases, 10 ng yTBP was used. Lanes 1, 7 and 13, control experiments in which no protein was added; lanes 6, 12 and 18, control experiments performed in the presence of only 24 ng hTFIIB and no yTBP. The positions of the yTBP-DNA and TFIIB-yTBP-DNA complexes are indicated. F, free oligonucleotides. ( B ) Formation of TFIIA-yTBP-DNA complex on the WT, TA 5 and (TA) 3 sequences as a function of increasing amounts of partially purified TFIIA: 0 (lanes 2, 8 and 14); 125 (lanes 3, 9 and 15); 250 (lanes 4, 10 and 16); 375 ng (lanes 5, 11 and 17). In all cases, 10 ng yTBP was used. Lanes 1, 7 and 13, control experiments in which no protein was added; lanes 6, 12 and 18, control experiments performed in the presence of only 24 ng TFIIA and no yTBP. The positions of the yTBP-DNA and TFIIA-yTBP-DNA complexes are indicated. F, free oligonucleotides. ( C ) Formation of the TFIIA-TFIIB-yTBP-DNA complex on the WT, TA 5 and (TA) 3 sequences is presented at two different amounts of added TFIIA: 125 (lanes 5, 11 and 17); 250 ng (lanes 6, 12 and 18). In all cases, 10 ng yTBP and 12 ng hTFIIB were used. Lanes 3-4, 9-10 and 15-16, formation of the TFIIA-TBP-DNA complexes in the absence of added hTFIIB at the two different amounts of TFIIA indicated before. Control experiments performed in the presence of only yTBP (lanes 2, 8 and 14), of only TFIIA (lane 19), of only TFIIB (lane 20) or in the absence of any added protein (lanes 1, 7 and 13) are also presented. The positions of the TFIIA-TFIIB-yTBP-DNA and TFIIA-yTBP-DNA complexes are indicated. F, free oligonucleotides. ( D ) The TA 5 promoter is transcriptionally inactive even in the presence of excess TFIIA and/or TFIIB. Transcriptional activity of the WT and TA 5 templates was assayed as a function of increasing amounts of added: TFIIA (50 ng, lanes 3 and 10; 500 ng, lanes 4 and 11); hTFIIB (2 ng, lanes 5 and 12; 20 ng, lanes 6 and 13); both (250 ng TFIIA plus 10 ng hTFIIB, lanes 7 and 14). All experiments were performed with 200 ng template, 8 [mu]l PC 0.5 M fraction and 30 ng yTBP. Control experiments performed in the absence of any added protein (lanes 1 and 8) or in the presence of only yTBP (lanes 2 and 9) are also presented. The positions of a recovery control (*) and full-length transcripts (+1) are indicated.

All these results indicate that TBP has a significant affinity for the inactive TA 5 sequence, which is only ~5-fold lower than for the active WT or (TA) 3 sequences. The interaction of TBP with the TA 5 sequence is surprising, because TA 5 -containing promoters are very poorly transcribed, if at all, both in vitro and in vivo ( 11 , 12 ; Fig. 1 B). These results suggest that the transcriptional incompetence of the TA 5 sequence may not only be the consequence of poor TBP binding, but may also be due to other factors. In addition, WT- and (TA) 3 -containing promoters are roughly equally transcribed, despite stronger TBP binding to the (TA) 3 sequence (Fig. 1 B), indicating a lack of correlation between TBP binding and basal promoter activity.

The TBP-TA 5 complex cannot be efficiently recognised by TFIIA and TFIIB

The efficiency of formation of the next two intermediates in the assembly of a productive pre-initiation complex, the TFIIA-TBP-DNA and TFIIB-TBP-DNA complexes ( 20 ), has been determined for the three sequences described above.

In the case of the TA 5 sequence, formation of the TFIIB-TBP-DNA complex is very inefficient, while WT and (TA) 3 yielded very stable, roughly equivalent ternary complexes (Fig. 4 A). Remarkably, an initially equivalent binding to both WT and TA 5 results in very different efficiencies of TFIIB-TBP-DNA complex formation; on the other hand, clearly different efficiencies of formation of the TBP-DNA complex on WT and (TA) 3 result in equivalent TFIIB-TBP-DNA complex formation. A similar situation was observed when formation of the TFIIA-TBP-DNA complex was investigated. Figure 4 B shows that formation of the TFIIA-TBP-DNA complex is less efficient, by at least an order of magnitude, on TA 5 than on WT or (TA) 3 (which are similar to each other). These results indicate that though TBP can bind to the TA 5 sequence, the resulting TBP-TA 5 complex is not efficiently recognised by TFIIB or TFIIA, providing a much better correlation with the transcriptional efficiencies of the sequences as basal promoters (Fig. 1 B). Nevertheless, on the TA 5 sequence the relative efficiency of formation of the TFIIA-TBP-TA 5 complex is significantly higher than for the TFIIB-TBP-TA 5 complex (compare Fig. 4 A and B). These results indicate that loading of TFIIA onto the TBP-TA 5 complex is less strongly affected than TFIIB loading. TFIIA is known to stabilise the interaction of TBP with the TATA box. It is therefore conceivable that it might help stabilise the interaction of TFIIB with TBP on TA 5 and eventually bring it back to a normal level. This possibility was assessed by studying formation of the TFIIA-TFIIB-TBP-DNA complex on the three sequences used. As shown in Figure 4 C, formation of this quaternary complex is seriously compromised in the case of the TA 5 sequence. Again, formation of this complex on WT and (TA) 3 is very similar and efficient, as expected. However, formation of the TFIIB-TFIIA-TBP-DNA complex on the TA 5 sequence is still noticeable, though less efficient, indicating that TFIIB loading is facilitated in the presence of TFIIA (compare Fig. 4 A and C). This result and the fact that the in vitro transcription system we use is basically devoid of TFIIA prompted us to check whether, in the presence of TFIIA, TA 5 might recover some activity in transcription. Figure 4 D shows that addition of increasing amounts of TFIIA, TFIIB or both does not result in increased TA 5 transcription, which is never above background in any case. On the other hand, WT shows normal levels of transcription under all conditions except in the presence of large amounts of TFIIA, where it is lower (Fig. 4 D, lane 4). Identical results were obtained using a complete nuclear HeLa extract, heat inactivated to destroy endogenous TBP activity and complemented as above (not shown). Therefore, the TA 5 sequence is transcriptionally inactive even in the presence of large amounts of TFIIA and/or TFIIB.

DNase I footprinting experiments reveal important differences in the way TBP interacts with the intrinsically curved TA 5 sequence

The results presented above indicate that the lack of transcription from the promoter having the TA 5 sequence should not only be attributed to a difference in its affinity for TBP, but also to the inability of other basal transcription factors, in particular TFIIB, to recognise the preformed TBP-TA 5 complex. As TBP interacts free in solution with both TFIIB and TFIIA (reviewed in 3 ), the lower efficiency observed in formation of the early steps of the pre-initiation complex on the TA 5 sequence is likely to reflect structural peculiarities of the initial TBP-TA 5 interaction. Actually, DNase I footprints of the TBP-TA 5 complex show some important differences with respect to the footprints obtained with the WT and (TA) 3 sequences (Fig. 3 ). A classical TBP footprint can be observed over the -34 to -21 region on the top strand and over -37 to -19 on the bottom strand with both WT and (TA) 3 probes (Fig. 3 A and B). However, in the case of the TA 5 sequence a striking lack of protection was observed at residues A(-29) and A(-30) (Fig. 3 A, indicated by asterisks in Fig. 3 D), situated in a central position on the top strand. As a consequence, the footprint is split into two halves. Protection on the 5'-half is slightly weaker than on the 3'-half (shown schematically as a gradient of grey in Fig. 3 D). Note that the central residues on the bottom strand are protected. The addition of TFIIB does not result in any major change in the footprints (data not shown; 21 , 22 ). These results strongly suggest that the structure of the TBP-TA 5 complex is different.

DNA deformability is likely to be an important determinant of the interaction of TBP with DNA because binding of TBP to a TATA box sequence induces a major conformational change in the DNA which results in the formation of two sharp kinks at either end of the TATA sequence. Between the kinks the DNA is smoothly curved towards the major groove and partially underwound. Depending upon the precise nucleotide sequence, A/T-rich sequences might have different structural characteristics ( 23 ) and, in particular, homoadenine runs are known to be intrinsically curved ( 24 ). Therefore, the differential structural organisation of the TBP-TA 5 complex could have arisen from the particular conformational properties of the DNA substrate. Taking this possibility into consideration, a circular permutation analysis of the three sequences studied here was performed. The TA 5 sequence was shown to have clear differences in electrophoretic mobility depending on the internal position of the TA 5 sequence (Fig. 5 , lanes 5-7). In comparison, (TA) 3 does not show any difference and WT shows only a minor change (compare lanes 8-10 and 2-4 respectively). These data show that the TA 5 sequence is intrinsically curved with an estimated angle of 19o.


Figure 5 . Circular permutation analysis of the WT, TA 5 and (TA) 3 sequences. The electrophoretic mobility of the 175 bp band generated by digestion of pBend2-WT (lanes 2-4), pBend2-TA 5 (lanes 5-7) and pBend2-(TA) 3 (lanes 8-10) with Bgl II, Pvu II and Bam HI was assayed on a 7% polyacrylamide gel run at 4oC in 1* TBE. The inserts are in a central position when digested with Pvu II. M, DNA molecular mass markers (lanes 1 and 12).

DISCUSSION

An increasing number of DNA binding proteins with very little in common are being found to interact with DNA through its minor groove. These include fairly abundant nuclear proteins such as HMG1/2 ( 25 , 26 ), HMGI/Y ( 27 ), transcription factors of the HMG box family ( 28 , 29 ), basal transcriptional factors such as TBP ( 4 , 5 ), recombination proteins ( 30 , 31 ), etc. However, the molecular bases of the specific interactions of proteins with DNA in the minor groove are poorly understood and, in fact, many of them have loose sequence specificities. The reason for that has to be found in the lack of information about sequence composition in the minor groove. This is particularly evident in the case of A/T-rich sequences, where the thymine O2 and adenine N3 groups that can participate in hydrogen bonding are stereochemically equivalent, making A.T and T.A base pairs difficult to discriminate. In this respect, TBP constitutes a particularly interesting and well-studied case. TBP binds the TATA box consensus core motif TATAAA with high affinity, but its sequence preferences are not yet completely understood ( 8 , 9 ). The protein has been shown to promote transcription from a large variety of A/T-rich sequences, but some mutations of the TATA box consensus sequence, especially a T -> A change at position -29, abolish transcription both in vitro and in vivo ( 11 , 12 ). Here we have addressed the question of how the transcription machinery discriminates between active and inactive TATA sequences and at what level this discrimination takes place. From our results, we conclude that there is no direct correlation between TBP binding to TATA boxes and basal promoter activity (Fig. 1 ). TBP binds both the transcriptionally inactive TA 5 sequence and the active WT or (TA) 3 sequences, the affinity for the TA 5 sequence being only 5-fold lower than for WT and (TA) 3 (Fig. 3 ). This slight decrease in affinity is unlikely to explain, on its own, the complete lack of transcriptional activity of the TA 5 sequence. Indeed, similar differences in affinity have been observed between otherwise functional TATA sequences, such as the AdMLP and the yeast CYC1-52 TATA boxes ( 19 ). Furthermore, the stabilities of the TBP-TA 5 and TBP-WT complexes are very similar, as observed by EMSA (Fig. 2 ). The results reported here suggest that discrimination between functional and non-functional promoters takes place at the level of formation of the next intermediates. The TBP-TA 5 complex cannot efficiently interact with either TFIIB or TFIIA. In addition, loading of RAP30 (the TFIIF small subunit), which is responsible for the recruitment of RNA polymerase II, is undetectable on the TA 5 sequence, while it is normal on WT and (TA) 3 sequences (not shown). As a consequence of these poor interactions, formation of the pre-initiation complex on the TA 5 sequence is blocked. Others ( 32 ) have reported a larger difference in stability of the complex formed by TBP with a TA 6 sequence when compared with the TATA box of the AdML promoter. This difference can be explained by the completely different sequence context in which our study was performed and also by the fact that the AdMLP TATA box is one of the strongest minimal promoters known. In this respect, note that TBP shows significant affinities for a broad range of different DNA sequences, varying from 2-4 * 10 -9 M for TATA boxes to 5 * 10 -6 M for non-specific average DNA sequences ( 19 , 33 ).

The inability of TFIIB and other basal transcription factors to recognise the TBP-TA 5 complex likely arises from the different structure of the complex. Several results indicate that the structural organisation of the TBP-TA 5 complex differs from the structure of the complexes formed with transcriptionally active sequences. On the one hand, the DNase I footprinting patterns of the TBP-TA 5 complex show important differences when compared with the patterns of complexes formed with the WT and (TA) 3 sequences (Fig. 3 ). Basically, the central residues and the 5'-side are more sensitive to DNase I cleavage in the TBP-TA 5 complex than in the TBP-WT or TBP-(TA) 3 complexes. Consistent with this interpretation, the 5'-side also shows a higher reactivity with hydroxyl radicals in the TBP-TA 5 complex than in the complexes formed with the functional sequences (not shown). Finally, it was shown that a core version of yTBP hardly bends a closely related TA 6 sequence ( 32 ). Altogether these results strongly indicate that the structure of the TBP-TA 5 complex is different. From our results it is difficult to determine the precise structural organisation of the TBP-TA 5 complex. However, a fundamental difference between the three sequences studied here relates to the intrinsically curved character of the TA 5 sequence (Fig. 5 ). The curved character of the sequence is expected to interfere with the usual path of the DNA underneath the protein saddle, so that binding of TBP to the TA 5 sequence may not be able to induce the conformational change in the DNA that leads to formation of a productive complex. In fact, the high level of DNase I digestion of the 5'-side in the TBP-TA 5 complex strongly suggests that the TBP-TA 5 interaction occurs principally on the 3'-half of the sequence, likely using one half of the TBP bipartite structure ( 34 ). The weaker interaction with the 5'-side can likely be explained as the result of the unfavourable angle generated by the DNA sequence itself around that position. These two possible modes of interaction of TBP with A/T-rich sequences are schematically presented in Figure 6 .


Figure 6 . Schematic representation of the two possible ways of interaction of yTBP with the transcriptionally competent WT and (TA) 3 sequences (left panel) and the inactive TA 5 sequence (right panel). In the case of the yTBP-TA 5 complex, the protein-DNA contacts occurring in the 5'-side of the TA 5 sequence are distorted due to the intrinsic curvature and rigidity of the DNA sequence, resulting in occlusion and/or distortion of the TFIIB binding site. The complexes with the WT and (TA) 3 sequences are schematically drawn after the data derived from the structure of the complexes formed with the TATAAAAG and TATATAAT sequences.

A different structural architecture of the TBP-DNA complex, such as that shown in Figure 6 , is likely to affect TFIIB binding severely. TFIIB does not directly interact with DNA and its loading on the TBP-TATA complex relies on interaction with TBP. In fact, the primary interaction site of human TFIIB has recently been mapped very close to the C-terminal stirrup of yTBP (residues 187-191, regions S2'-S3'), which occurs very close to the DNA binding site for the 5'-end of the TATA box sequence. From those results TFIIB has been suggested to bind beneath the concave surface of TBP ( 22 ). In addition, the co-crystal structure of the human C-terminal domains of TFIIB- Arabidopsis TBP2-TATA box has recently been solved and showed that TFIIB binds mainly to the homologous region of Arabidopsis TBP (residues 143-147, regions S2'-S3'). ( 35 ). As this is a highly conserved region among yeast, Arabidopsis and human TBPs, we can reasonably assume that TFIIB primarily interacts with this region on yTBP. Therefore, the main TFIIB binding site on yTBP occurs at the structural domain interacting with the 5'-site of the TATA box. As shown by DNase I footprinting (Fig. 3 ), this region shows a different structural geometry in the TBP-TA 5 complex. As schematically shown in Figure 6 , a different structural arrangement of this region could result in occlusion of the primary binding site for TFIIB on TBP. In addition, recent results indicate that TFIIB acts as a clamp on the TBP-TATA complex, showing secondary interactions with the DNA regions immediately upstream and downstream of the TATA box ( 22 , 35 ). The remarkable DNA bending induced by TBP seems to be important for TFIIB binding, because it brings the upstream and downstream sequences closer to each other ( 35 ). A change in the path of the DNA, such as that proposed to occur in the TBP-TA 5 complex (Fig. 6 ), would also impair these secondary interactions with DNA, rendering TFIIB binding extremely difficult. This hypothesis also explains the results presented here on the formation of TFIIA-containing complexes. Analyses by site-directed mutagenesis ( 36 , 37 ) and X-ray crystallography ( 38 , 39 ) have shown that binding of TFIIA to the TBP-DNA complex occurs through the TBP domain interacting with the 3'-end of the TATA box sequence, away from the TFIIB binding site. From the DNase I footprinting results, interaction of TBP with the 3'-end of the TA 5 sequence is not as dramatically distorted as its interaction with the 5'-end. Therefore, and in good agreement with our results, TFIIA binding should in principle be less affected by the altered geometry of the TBP-TA 5 complex. However, TFIIA also interacts with the DNA, acting, like TFIIB, as a clamp by binding to both TBP and DNA ( 35 , 38 , 39 ). The altered geometry of the TBP-TA 5 complex is likely to affect the spatial arrangement of these secondary binding sites and, therefore, the loading of TFIIA onto the complex.

An alternative explanation we cannot discard at the moment might invoke a conformational change in TBP upon interaction with TA 5 that would somehow prevent TFIIB binding and distort TFIIA binding. However, this does not seem very likely, since all available data indicate that the structure of TBP remains largely unaffected after its interaction with DNA ( 6 - 9 , 35 , 38 , 39 ).

In summary, our results indicate that, as expected from its binding mode, TBP can interact with many different A/T-rich sequences and, in this sense, it does not show real sequence specificity. Functional TATA sequences produce transcriptionally competent complexes which are then properly recognised by the remaining basal transcription factors. The non-productive complexes formed with other A/T-rich sequences are not efficiently recognised by either TFIIB, TFIIA or RAP30, likely due to an inappropriate geometry. From this point of view, the relaxed specificity of TBP recognition of A/T-rich sequences would be corrected and/or modulated by interaction with other basal transcription factors, mainly TFIIB. The lack of such interaction will predictably result in both instability of TBP binding and, more important, blockage of the pathway to the formation of the pre-initiation complex. This establishes a correlation between transcription activity and TFIIB-TBP-DNA complex formation.

ACKNOWLEDGEMENTS

We thank Danny Reinberg, Jean-Marc Egly and Jack Greenblatt for TFIIB, yTBP and RAP30 cDNAs respectively, Sam Gunderson and Marco Bianchi for the G-less[180] and pBend2 plasmids and Ramón Eritja for oligonucleotide synthesis. We are grateful to Gemma Moll and Jenny Colom for excellent technical support and all other members of the Department for scientific discussion and support. P.C. was supported by a doctoral fellowship from the Ministerio de Educación y Ciencia and J.B. by a CSIC post-doctoral contract. The financial support of grants PB93-102 from the Spanish DGICYT and PL-932217 from the CEC is gratefully acknowledged. This work was carried out within the framework of the `Centre de Referéncia en Biotecnologia' of the Generalitat de Catalunya.

REFERENCES

1 Buratowski,S., Hahn,S., Guarente,L. and Sharp,P.A. (1989) Cell, 56, 549-561. MEDLINE Abstract

2 Buratowski,S. (1994) Cell, 77, 1-3. MEDLINE Abstract

3 Conaway,R.C. and Conaway,J.W. (1993) Annu. Rev. Biochem., 62, 161-190. MEDLINE Abstract

4 Lee,D.K., Horikoshi,M. and Roeder,R.G. (1991) Cell, 67, 1241-1250. MEDLINE Abstract

5 Starr,D.B. and Hawley,D.K. (1991) Cell, 67, 1231-1240. MEDLINE Abstract

6 Nikolov,D.B., Hu,S.-H., Lin,J., Gasch,A., Hoffmann,A., Horikoshi,M., Chua,N.-H., Roeder,R.G. and Burley,S.K. (1992) Nature, 360, 40-46. MEDLINE Abstract

7 Chasman,D.I., Flaherty,K.M., Sharp,P.A. and Kornberg,R.D. (1993) Proc. Natl. Acad. Sci. USA, 90, 8174-8178. MEDLINE Abstract

8 Kim,Y., Geiger,J.H., Hahn,S. and Sigler,P.B. (1993) Nature, 365, 512-520. MEDLINE Abstract

9 Kim,J.L., Nikolov,D.B. and Burley,S.K. (1993) Nature, 365, 520-527. MEDLINE Abstract

10 Horikoshi,M., Bertuccioli,C., Takada,R., Wang,J., Yamamoto,T. and Roeder,R.G. (1992) Proc. Natl. Acad. Sci. USA, 89, 1060-1064. MEDLINE Abstract

11 Chen,W. and Struhl,K. (1988) Proc. Natl. Acad. Sci. USA, 85, 2691-2695. MEDLINE Abstract

12 Wobbe,C.R. and Struhl,K. (1990) Mol. Cell. Biol., 10, 3859-3867. MEDLINE Abstract

13 Ha,I., Lane, W.S. and Reinberg,D. (1991) Nature, 352, 689-695. MEDLINE Abstract

14 Meisterernst,M., Roy,A.L., Lieu,H.M. and Roeder,R.G. (1991) Cell, 66, 981-993. MEDLINE Abstract

15 Bernués,J., Simmen,K.A., Lewis,J.D., Gunderson,S.I., Polycarpou-Schwarz,M., Moncollin,V., Egly,J.-M. and Mattaj,I.W. (1993) EMBO J., 12, 3573-3585. MEDLINE Abstract

16 Hoopes,B.C., LeBlanc,J.F. and Hawley,D.K. (1992) J. Biol. Chem., 267, 11539-11547. MEDLINE Abstract

17 Auble,D.T. and Hahn,S. (1993) Genes Dev., 7, 844-856. MEDLINE Abstract

18 Kim,J., Zwieb,C., Wu,C. and Adhya,S. (1989) Gene, 85, 15-23. MEDLINE Abstract

19 Hahn,S., Buratowski,S., Sharp,P.A. and Guarente,L. (1989) Proc. Natl. Acad. Sci. USA, 86, 5718-5722. MEDLINE Abstract

20 Maldonado,E., Ha,I., Cortes,P., Weis,L. and Reinberg,D. (1990) Mol. Cell. Biol., 10, 6335-6347. MEDLINE Abstract

21 Malik,S., Lee,D.K. and Roeder,R.G. (1993) Mol. Cell. Biol., 13, 6253-6259. MEDLINE Abstract

22 Lee,S. and Hahn,S. (1995) Nature, 376, 609-612. MEDLINE Abstract

23 Carrera,P., Martínez-Balbás,M.A., Portugal,J. and Azorín,F. (1991) Nucleic Acids Res., 19, 5639-5644. MEDLINE Abstract

24 Koo,H.-S., Wu,H.-M. and Crothers,D.M. (1986) Nature, 320, 501-506. MEDLINE Abstract

25 Falciola,L., Murchie,A.I.H., Lilley,D.M.J. and Bianchi,M.E. (1994) Nucleic Acids Res., 22, 285-292. MEDLINE Abstract

26 Locker,D., Decoville,M., Maurizot,J.C., Bianchi,M.E. and Leng,M. (1995) J. Mol. Biol., 246, 243-247. MEDLINE Abstract

27 Strauss,F. and Varshavsky,A. (1984) Cell, 37, 889-901. MEDLINE Abstract

28 Giese,K., Cox,J. and Grosschedl,R. (1992) Cell, 69, 185-195. MEDLINE Abstract

29 van de Wetering,M. and Clevers,H. (1992) EMBO J., 11, 3039-3044. MEDLINE Abstract

30 Bhattacharyya,A., Murchie,A.I.H., von Kitzing,E., Diekmann,S., Kemper,B. and Lilley,D.M.J. (1991) J. Mol. Biol., 221, 1191-1207. MEDLINE Abstract

31 Duckett,D.R., Murchie,A.I.H., Bhattacharyya,A., Clegg,R.M., Diekmann,S., von Kitzing,E. and Lilley,D.M.J. (1992) Eur. J. Biochem., 207, 285-295.

32 Starr,D.B., Hoopes,B.C. and Hawley,D.K. (1995) J. Mol. Biol., 250, 343-446.

33 Coleman,R.A. and Pugh,B.F. (1995) J. Biol. Chem., 270, 13850-13859. MEDLINE Abstract

34 Yamamoto,T., Horikoshi,M., Wang,J., Hasegawa,S., Weil,P.A. and Roeder,R.G. (1992) Proc. Natl. Acad. Sci. USA, 89, 2844-2848. MEDLINE Abstract

35 Nikolov,D.B., Chen,H., Halay,E.D., Usheva,A.A., Lee,D.K., Roeder,R.G. and Burley,S.K. (1995) Nature, 377, 119-128. MEDLINE Abstract

36 Buratowski,S. and Zhou,H. (1992) Science, 255, 1130-1132. MEDLINE Abstract

37 Lee,D.K., Dejong,J., Hashimoto,S., Horikoshi,M. and Roeder,R.G. (1992) Mol. Cell. Biol., 12, 5189-5196. MEDLINE Abstract

38 Geiger,J.H., Hahn,S., Lee,S. and Sigler,P.B. (1996) Science, 272, 830-836. MEDLINE Abstract

39 Tan,S., Hunziker,Y., Sargent,D.F. and Richmond,T.J. (1996) Nature, 381, 127-134. MEDLINE Abstract


Return

* To whom correspondence should be addressed

+ Present address: Abteilung Molekulare Entwicklungsbiologie, MPI für Biophysikalische Chemie, D-37018 Göttingen, Germany
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. J. Stewart, J. A. Fischbeck, X. Chen, and L. A. Stargell
Non-optimal TATA Elements Exhibit Diverse Mechanistic Consequences
J. Biol. Chem., August 11, 2006; 281(32): 22665 - 22673.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
W. Wang, L. Wang, A. Endoh, G. Hummelke, C. L Hawks, and P. J Hornsby
Identification of {alpha}-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex
J. Endocrinol., January 1, 2005; 184(1): 85 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Upadhyaya, M. Khan, T.-C. Mou, M. Junker, D. M. Gray, and J. DeJong
The Germ Cell-specific Transcription Factor ALF. STRUCTURAL PROPERTIES AND STABILIZATION OF THE TATA-BINDING PROTEIN (TBP)-DNA COMPLEX
J. Biol. Chem., September 6, 2002; 277(37): 34208 - 34216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Jung, Y. Mikata, and S. J. Lippard
Kinetic Studies of the TATA-binding Protein Interaction with Cisplatin-modified DNA
J. Biol. Chem., November 16, 2001; 276(47): 43589 - 43596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Espinas, E. Jimenez-Garcia, A. Vaquero, S. Canudas, J. Bernues, and F. Azorin
The N-terminal POZ Domain of GAGA Mediates the Formation of Oligomers That Bind DNA with High Affinity and Specificity
J. Biol. Chem., June 4, 1999; 274(23): 16461 - 16469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sutrias-Grau, M. E. Bianchi, and J. Bernues
High Mobility Group Protein 1 Interacts Specifically with the Core Domain of Human TATA Box-binding Protein and Interferes with Transcription Factor IIB within the Pre-initiation Complex
J. Biol. Chem., January 15, 1999; 274(3): 1628 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Brinkman, I. Dahlke, J. E. Tuininga, T. Lammers, V. Dumay, E. de Heus, J. H. G. Lebbink, M. Thomm, W. M. de Vos, and J. van der Oost
An Lrp-like Transcriptional Regulator from the Archaeon Pyrococcus furiosus Is Negatively Autoregulated
J. Biol. Chem., December 1, 2000; 275(49): 38160 - 38169.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (222K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bernues, J
Right arrow Articles by Azorin, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernues, J
Right arrow Articles by Azorin, F
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?